======= ALDH1L2 ======= == Gene Information == * **Official Symbol**: ALDH1L2 * **Official Name**: aldehyde dehydrogenase 1 family member L2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=160428|160428]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q3SY69|Q3SY69]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ALDH1L2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ALDH1L2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613584|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of both the aldehyde dehydrogenase superfamily and the formyl transferase superfamily. This member is the mitochondrial form of 10-formyltetrahydrofolate dehydrogenase (FDH), which converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2 in an NADP(+)-dependent reaction, and plays an essential role in the distribution of one-carbon groups between the cytosolic and mitochondrial compartments of the cell. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2010]. * **UniProt Summary**: N/A |Aldedh| |Formyl trans C| |Formyl trans N| |hydroxymethyl-, formyl- and related transferase activity| |formyltetrahydrofolate dehydrogenase activity| |10-formyltetrahydrofolate catabolic process| |folic acid-containing compound catabolic process| |pteridine-containing compound catabolic process| |10-formyltetrahydrofolate metabolic process| |aldehyde dehydrogenase (NAD) activity| |coenzyme catabolic process| |dicarboxylic acid catabolic process| |tetrahydrofolate metabolic process| |folic acid metabolic process| |one-carbon metabolic process| |folic acid-containing compound metabolic process| |cellular modified amino acid catabolic process| |pteridine-containing compound metabolic process| |cofactor catabolic process| |water-soluble vitamin metabolic process| |dicarboxylic acid metabolic process| |vitamin metabolic process| |cellular modified amino acid metabolic process| |coenzyme metabolic process| |carboxylic acid catabolic process| |organic acid catabolic process| |mitochondrial matrix| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |small molecule catabolic process| |cofactor metabolic process| |aromatic compound catabolic process| |organic cyclic compound catabolic process| |drug metabolic process| |cellular amide metabolic process| |carboxylic acid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound catabolic process| |mitochondrion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-1.9| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.88| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.78| |[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.79| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10901 * **Expression level (log2 read counts)**: 2.37 {{:chemogenomics:nalm6 dist.png?nolink |}}